Start
Entdecken
nav.journalClub
Trends
Mehr
synapse
⌘+K
Sprache
Deutsch
Deutsch
Exploring Current and Emerging Therapies for Patients With Primary Biliary Cholangitis | Synapse
March 3, 2026
Open Access
Exploring Current and Emerging Therapies for Patients With Primary Biliary Cholangitis
GL
Gary R. Lichtenstein
Key Points
Innovative therapies significantly improve outcomes for primary biliary cholangitis patients, addressing bile acid metabolism disturbances.
The review highlights the efficacy of emerging treatments and established therapies in managing autoimmune liver disease.
Observational analysis of current literature shows promising results for new immunotherapy approaches and bile acid management.
Future developments in therapy could enhance care for those with primary biliary cholangitis; further validation is necessary.
Read Full Paper
externally
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Cite This Study
Copy
Gary R. Lichtenstein (Sat,) studied this question.
synapsesocial.com/papers/69a75fdcc6e9836116a2c10b
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper